Portal:RareDisease/FeaturedPathways
From WikiPathways
(Difference between revisions)
Line 93: | Line 93: | ||
List of featured pathways: | List of featured pathways: | ||
- | * [[Pathway: | + | * [[Pathway:WP2059]] - Alzheimers Disease |
+ | * [[Pathway:WP2371]] - Parkinsons Disease Pathway | ||
* [[Pathway:WP2447]] - Amyotrophic lateral sclerosis (ALS) | * [[Pathway:WP2447]] - Amyotrophic lateral sclerosis (ALS) | ||
* [[Pathway:WP3569]] - Fanconi Anemia Pathway | * [[Pathway:WP3569]] - Fanconi Anemia Pathway | ||
- | * [[Pathway: | + | * [[Pathway:WP3584]] - MECP2 and Associated Rett Syndrome |
- | * [[Pathway: | + | * [[Pathway:WP3853]] - ERK Pathway in Huntington's Disease |
- | + | * [[Pathway:WP3995]] - Prion disease pathway | |
- | * [[Pathway: | + | * [[Pathway:WP3998]] - Prader-Willi and Angelman Syndrome |
- | * [[Pathway: | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
* [[Pathway:WP4153]] - Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses | * [[Pathway:WP4153]] - Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses | ||
+ | * [[Pathway:WP4156]] - Disorders of Phenylalanine and Tetrahydrobiopterin | ||
* [[Pathway:WP4220]] - Neurotransmitter Disorders | * [[Pathway:WP4220]] - Neurotransmitter Disorders | ||
* [[Pathway:WP4224]] - Purine Disorders | * [[Pathway:WP4224]] - Purine Disorders | ||
* [[Pathway:WP4225]] - Pyrimidine Disorder | * [[Pathway:WP4225]] - Pyrimidine Disorder | ||
- | * [[Pathway: | + | * [[Pathway:WP4228]] - Vitamine B6-Dependent and Responsive Disorders |
- | * [[Pathway: | + | * [[Pathway:WP4236]] - Disorders of the Krebs Cycle |
+ | * [[Pathway:WP4259]] - Disorders of Folate Metabolism and Transport | ||
+ | * [[Pathway:WP4271]] - Vitamin B12 Disorders | ||
+ | * [[Pathway:WP4288]] - MTHFR deficiency | ||
+ | * [[Pathway:WP4292]] - Sulphur Amino Acids | ||
+ | * [[Pathway:WP4297]] - Thiamine Disorders | ||
+ | * [[Pathway:WP4298]] - Viral Acute Myocarditis | ||
+ | * [[Pathway:WP4299]] - Lamin A-processing pathway | ||
+ | * [[Pathway:WP4312]] - Rett syndrome causing genes | ||
+ | * [[Pathway:WP4320]] - The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome | ||
+ | * [[Pathway:WP4504]] - Cysteine and Methionine catabolism | ||
+ | * [[Pathway:WP4506]] - Tyrosine Metabolism | ||
+ | * [[Pathway:WP4507]] - Molybdenum (Moco) cofactor biosynthesis | ||
* [[Pathway:WP4518]] - Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases | * [[Pathway:WP4518]] - Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases | ||
* [[Pathway:WP4519]] - Cerebral Organic Acidurias | * [[Pathway:WP4519]] - Cerebral Organic Acidurias | ||
Line 122: | Line 126: | ||
* [[Pathway:WP4523]] - Classical pathway of steroidogenesis, including diseases | * [[Pathway:WP4523]] - Classical pathway of steroidogenesis, including diseases | ||
* [[Pathway:WP4524]] - The alternative pathway of fetal androgen synthesis | * [[Pathway:WP4524]] - The alternative pathway of fetal androgen synthesis | ||
+ | * [[Pathway:WP4535]] - Envelope proteins and their potential roles in EDMD physiopathology | ||
+ | * [[Pathway:WP4540]] - Pathways Regulating Hippo Signaling | ||
+ | * [[Pathway:WP4541]] - po-Merlin Signaling Dysregulation | ||
+ | * [[Pathway:WP4545]] - Oxysterols derived from cholesterol | ||
* [[Pathway:WP4549]] - Fragile X Syndrome | * [[Pathway:WP4549]] - Fragile X Syndrome | ||
* [[Pathway:WP4577]] - WDR45 autophagy related pathway | * [[Pathway:WP4577]] - WDR45 autophagy related pathway | ||
- | * [[Pathway: | + | * [[Pathway:WP4656]] - Joubert Syndrome |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
* [[Pathway:WP4657]] - 22q11.2 Deletion Syndrome | * [[Pathway:WP4657]] - 22q11.2 Deletion Syndrome | ||
- | |||
- | |||
* [[Pathway:WP4673]] - Genes involved in male infertility | * [[Pathway:WP4673]] - Genes involved in male infertility | ||
- | * [[Pathway: | + | * [[Pathway:WP4746]] - Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
* [[Pathway:WP4792]] - Purine metabolism | * [[Pathway:WP4792]] - Purine metabolism | ||
- | |||
* [[Pathway:WP4814]] - Somatic Sex determination | * [[Pathway:WP4814]] - Somatic Sex determination | ||
+ | * [[Pathway:WP4818]] - Conversion of Angiotensinogen to Angiotensin II | ||
+ | * [[Pathway:WP4823]] - Genes controlling renal nephrogenesis | ||
+ | * [[Pathway:WP4830]] - GDNF/RET signalling axis | ||
+ | * [[Pathway:WP4835]] - Peroxiredoxin 2 induced ovarian failure | ||
+ | * [[Pathway:WP4838]] - Regucalcin in proximal tubule epithelial kidney cells | ||
+ | * [[Pathway:WP4842]] - Mammalian disorder of sexual development | ||
+ | * [[Pathway:WP4844]] - The influence of laminopathies on Wnt signaling | ||
+ | * [[Pathway:WP4871]] - Kisspeptin/Kisspeptin Receptor System in the Ovary | ||
+ | * [[Pathway:WP4879]] - Interacting Laminopathic Pathways | ||
* [[Pathway:WP4905]] - 1q21.1 copy number variation syndrome | * [[Pathway:WP4905]] - 1q21.1 copy number variation syndrome | ||
* [[Pathway:WP4906]] - 3q29 copy number variation syndrome | * [[Pathway:WP4906]] - 3q29 copy number variation syndrome | ||
- | |||
- | |||
- |
Revision as of 07:51, 7 May 2020
Contents |
Rare diseases in general
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Copy number variation syndromes
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Laminopathies
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Inborn errors of metabolism
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Disorders of sex development
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
CAKUT (congenital anomalies of the kidney and urinary tract)
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
List of featured pathways:
- Pathway:WP2059 - Alzheimers Disease
- Pathway:WP2371 - Parkinsons Disease Pathway
- Pathway:WP2447 - Amyotrophic lateral sclerosis (ALS)
- Pathway:WP3569 - Fanconi Anemia Pathway
- Pathway:WP3584 - MECP2 and Associated Rett Syndrome
- Pathway:WP3853 - ERK Pathway in Huntington's Disease
- Pathway:WP3995 - Prion disease pathway
- Pathway:WP3998 - Prader-Willi and Angelman Syndrome
- Pathway:WP4153 - Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses
- Pathway:WP4156 - Disorders of Phenylalanine and Tetrahydrobiopterin
- Pathway:WP4220 - Neurotransmitter Disorders
- Pathway:WP4224 - Purine Disorders
- Pathway:WP4225 - Pyrimidine Disorder
- Pathway:WP4228 - Vitamine B6-Dependent and Responsive Disorders
- Pathway:WP4236 - Disorders of the Krebs Cycle
- Pathway:WP4259 - Disorders of Folate Metabolism and Transport
- Pathway:WP4271 - Vitamin B12 Disorders
- Pathway:WP4288 - MTHFR deficiency
- Pathway:WP4292 - Sulphur Amino Acids
- Pathway:WP4297 - Thiamine Disorders
- Pathway:WP4298 - Viral Acute Myocarditis
- Pathway:WP4299 - Lamin A-processing pathway
- Pathway:WP4312 - Rett syndrome causing genes
- Pathway:WP4320 - The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome
- Pathway:WP4504 - Cysteine and Methionine catabolism
- Pathway:WP4506 - Tyrosine Metabolism
- Pathway:WP4507 - Molybdenum (Moco) cofactor biosynthesis
- Pathway:WP4518 - Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases
- Pathway:WP4519 - Cerebral Organic Acidurias
- Pathway:WP4521 - Glycosylation and related congenital defects
- Pathway:WP4522 - Metabolic pathway of LDL, HDL and TG
- Pathway:WP4523 - Classical pathway of steroidogenesis, including diseases
- Pathway:WP4524 - The alternative pathway of fetal androgen synthesis
- Pathway:WP4535 - Envelope proteins and their potential roles in EDMD physiopathology
- Pathway:WP4540 - Pathways Regulating Hippo Signaling
- Pathway:WP4541 - po-Merlin Signaling Dysregulation
- Pathway:WP4545 - Oxysterols derived from cholesterol
- Pathway:WP4549 - Fragile X Syndrome
- Pathway:WP4577 - WDR45 autophagy related pathway
- Pathway:WP4656 - Joubert Syndrome
- Pathway:WP4657 - 22q11.2 Deletion Syndrome
- Pathway:WP4673 - Genes involved in male infertility
- Pathway:WP4746 - Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism
- Pathway:WP4792 - Purine metabolism
- Pathway:WP4814 - Somatic Sex determination
- Pathway:WP4818 - Conversion of Angiotensinogen to Angiotensin II
- Pathway:WP4823 - Genes controlling renal nephrogenesis
- Pathway:WP4830 - GDNF/RET signalling axis
- Pathway:WP4835 - Peroxiredoxin 2 induced ovarian failure
- Pathway:WP4838 - Regucalcin in proximal tubule epithelial kidney cells
- Pathway:WP4842 - Mammalian disorder of sexual development
- Pathway:WP4844 - The influence of laminopathies on Wnt signaling
- Pathway:WP4871 - Kisspeptin/Kisspeptin Receptor System in the Ovary
- Pathway:WP4879 - Interacting Laminopathic Pathways
- Pathway:WP4905 - 1q21.1 copy number variation syndrome
- Pathway:WP4906 - 3q29 copy number variation syndrome